HK WinHealth Pharma Group is a leading, fully integrated commercialization platform focused on bringing innovative and specialty therapies to Greater China and Asia‑Pacific. Our strengths span hematology‑oncology, renal and cardio‑renal diseases, respiratory and immunology, anti‑infectives, dermatology, and CNS disorders, with selective interest in rare conditions. We provide end‑to‑end capabilities across regulatory strategy, GMP manufacturing, market access, and large‑scale commercialization. With 800+ professionals, a network covering 25,000+ hospitals, and a Class A manufacturing credit rating, WinHealth is the trusted partner for multinational companies seeking compliant commercialization, distribution, and asset‑divestment solutions in China.